🇺🇸 FDA
Patent

US 8759325

Compositions and methods of treatment for inflammatory diseases

granted A61KA61K31/13A61K31/198

Quick answer

US patent 8759325 (Compositions and methods of treatment for inflammatory diseases) held by The Regents of the University of Oklahoma expires Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Oklahoma
Grant date
Tue Jun 24 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/13, A61K31/198, A61K31/355, A61K31/375